These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
673 related items for PubMed ID: 19996923
1. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. Barth RN, Nam AJ, Stanwix MG, Kukuruga D, Drachenberg CI, Bluebond-Langner R, Hui-Chou H, Shipley ST, Bartlett ST, Rodriguez ED. Transplantation; 2009 Dec 15; 88(11):1242-50. PubMed ID: 19996923 [Abstract] [Full Text] [Related]
2. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Majewski M, Korecka M, Joergensen J, Fields L, Kossev P, Schuler W, Shaw L, Wasik MA. Transplantation; 2003 May 27; 75(10):1710-7. PubMed ID: 12777861 [Abstract] [Full Text] [Related]
3. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates. Lellouch AG, Ng ZY, Rosales IA, Schol IM, Leonard DA, Gama AR, Colvin RB, Lantieri LA, Randolph MA, Cetrulo CL. Plast Reconstr Surg; 2020 Apr 27; 145(4):757e-768e. PubMed ID: 32221215 [Abstract] [Full Text] [Related]
4. Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival. Barth RN, Bluebond-Langner R, Nam A, Stanwix M, Shipley S, Bartlett ST, Rodriguez ED. Plast Reconstr Surg; 2009 Feb 27; 123(2):493-501. PubMed ID: 19182606 [Abstract] [Full Text] [Related]
5. Swine hemi-facial composite tissue allotransplantation: a model to study immune rejection. Kuo YR, Shih HS, Lin CC, Huang CC, Yang JC, Wu WS, Goto S, Chen CL, Lee WP. J Surg Res; 2009 May 15; 153(2):268-73. PubMed ID: 18708190 [Abstract] [Full Text] [Related]
6. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys. Yang H, Chen G, Kanai N, Shum J, Garcia B, Huang X, Min W, Luo Y, Dutartre P, Zhong R. Transplantation; 2003 Apr 27; 75(8):1166-71. PubMed ID: 12717197 [Abstract] [Full Text] [Related]
7. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Yoder B, Siemionow M. Transplant Proc; 2006 Jun 27; 38(5):1625-33. PubMed ID: 16797371 [Abstract] [Full Text] [Related]
8. Post-transplant lymphoproliferative disorder following pediatric heart transplantation. Mendoza F, Kunitake H, Laks H, Odim J. Pediatr Transplant; 2006 Feb 27; 10(1):60-6. PubMed ID: 16499589 [Abstract] [Full Text] [Related]
9. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival. Wang H, Ge W, Arp J, Zassoko R, Liu W, Ichim TE, Jiang J, Jevnikar AM, Garcia B. J Immunol; 2009 May 15; 182(10):5970-81. PubMed ID: 19414748 [Abstract] [Full Text] [Related]
10. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation. Mundinger GS, Munivenkatappa R, Drachenberg CB, Ha JS, Vaca EE, Shipley ST, Papadimitriou JC, Bartlett ST, Rodriguez ED, Barth RN. Transplantation; 2013 May 27; 95(10):1204-10. PubMed ID: 23694932 [Abstract] [Full Text] [Related]
11. Generation of donor hematolymphoid cells after rat-limb composite grafting. Ajiki T, Takahashi M, Inoue S, Sakuma Y, Oyama S, Kaneko T, Hakamata Y, Murakami T, Kume A, Kariya Y, Hoshino Y, Kobayashi E. Transplantation; 2003 Mar 15; 75(5):631-6. PubMed ID: 12640301 [Abstract] [Full Text] [Related]
12. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates. Maki T, Carville A, Stillman IE, Sato K, Kodaka T, Minamimura K, Ogawa N, Kanamoto A, Gottschalk R, Monaco AP, Marr-Belvin A, Westmoreland SV, Sehgal P. Transplantation; 2008 Mar 27; 85(6):893-902. PubMed ID: 18360273 [Abstract] [Full Text] [Related]
13. A heterotopic primate model for facial composite tissue transplantation. Silverman RP, Banks ND, Detolla LJ, Shipley ST, Panda A, Sanchez RA, Azimzadeh AM, Pierson RN, Wang D, Rodriguez ED, Holton LH, Bartlett ST. Ann Plast Surg; 2008 Feb 27; 60(2):209-16. PubMed ID: 18216518 [Abstract] [Full Text] [Related]
16. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW. J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438 [Abstract] [Full Text] [Related]
17. Impact of donor bone marrow on survival of composite tissue allografts. Siemionow M, Nasir S. Ann Plast Surg; 2008 Apr 10; 60(4):455-62. PubMed ID: 18362579 [Abstract] [Full Text] [Related]
19. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer. Muramatsu K, Valenzuela RG, Bishop AT. J Orthop Res; 2003 Nov 10; 21(6):1056-62. PubMed ID: 14554219 [Abstract] [Full Text] [Related]
20. Development of lymphoproliferative disease after liver transplantation. Marqués E, Jiménez C, Manrique A, Vallejo GH, Clemares M, Ortega P, Moreno E. Transplant Proc; 2008 Nov 10; 40(9):2988-9. PubMed ID: 19010169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]